ARTICLE | Distillery Therapeutics
Neurology
May 16, 2018 5:50 PM UTC
In vitro and mouse studies suggest a peptide-based agent that captures Aβ42 and induces autophagy could help treat AD. The “nanosweeper” agent consists of a PEGylated GKLVFF peptide that binds Aβ42 li...
BCIQ Company Profiles